Physician

Franklin Enrique Fuenmayor-Cardozo, M.D.

According to 2025 Medicare claims, Franklin Fuenmayor-Cardozo, M.D. (NPI: 1467659854) practices internal medicine in the Macon-Bibb County, GA market, with the plurality of this provider's patient population coming from Bibb, GA. This provider's primary affiliated billing organization is KIDNEY CENTER OF CENTRAL GEORGIA, LLC (NPI: 1962708891; TIN: 27-4662319) and primary practice location at 31201-2102. Fuenmayor-Cardozo is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Fuenmayor-Cardozo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 660 traditional Medicare patients, billed 4,983 HCPCS/CPT codes, and received $419,951 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 6,047 prescription claims across 512 beneficiaries totaling $989,381 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2020 DME data shows 32 claims. Open Payments data shows 66 records totaling $1,585. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $22,513 to $989,381. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	620	4,059	$281,589
2016	625	4,024	$312,533
2017	614	4,443	$344,731
2018	726	5,660	$469,180
2019	828	6,269	$514,490
2020	852	6,623	$485,489
2021	756	5,433	$404,480
2022	703	4,646	$337,976
2023	635	4,595	$387,099
2024	660	4,983	$419,951

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	87	451	$22,513
2016	140	828	$130,089
2017	184	1,730	$254,424
2018	229	2,329	$337,394
2019	274	2,642	$630,625
2020	335	2,952	$422,605
2021	323	2,880	$477,807
2022	360	3,403	$711,799
2023	440	4,553	$944,226
2024	512	6,047	$989,381

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	130	$27,394
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	32	$1,406
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	330	480	$128
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	106	442	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	217	493	$59
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	399	2,398	$58
90935	Hemodialysis procedure with physician evaluation	130	462	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	591	22,261	$411,122
Rayaldee	Calcifediol	71	2,346	$102,137
Jardiance	Empagliflozin	119	4,448	$87,593
Velphoro	Sucroferric Oxyhydroxide	22	780	$53,057
Kerendia	Finerenone	57	2,310	$49,290

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	66	$1,585	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Franklin Enrique Fuenmayor-Cardozo, M.D.?

Tedicare shows public-source Medicare data for Franklin Enrique Fuenmayor-Cardozo, M.D. (NPI 1467659854), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Franklin Enrique Fuenmayor-Cardozo, M.D. have ACO affiliation data?

Franklin Enrique Fuenmayor-Cardozo, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Franklin Enrique Fuenmayor-Cardozo, M.D.?

Franklin Enrique Fuenmayor-Cardozo, M.D. is linked to KIDNEY CENTER OF CENTRAL GEORGIA, LLC (billing NPI 1962708891) in the available physician profile data.

Does Franklin Enrique Fuenmayor-Cardozo, M.D. have Open Payments data?

Franklin Enrique Fuenmayor-Cardozo, M.D. has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.